Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1**Comment**- IMP inhalation solution identical to ventavis inhalation solution, but IMP is in a different volume presentation. Please see covering letter.[1] Iloprost[1] Iloprost 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
21 mg QD to 15 mg QD PF-06649751[1] Tavapadon[1] Tavapadon 💬 [2] DRD1,
DRD5 💬 		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6 💬
31 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study)[1] Tavapadon[1] Tavapadon 💬 [2] DRD1,
DRD5 💬 		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6 💬
410% Metronidazole Ointment
(METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL)		[1] Metronidazole (Metronidazole Topical Cream)[1] Metronidazole (METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL) 💬 --[1] 96 💬
515 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD[1] Tavapadon[1] Tavapadon 💬 [2] DRD1,
DRD5 💬 		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6 💬
615N2-tofacitinib[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
73 mg QD to 15 mg QD PF-06649751[1] Tavapadon[1] Tavapadon 💬 [2] DRD1,
DRD5 💬 		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6 💬
83 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)[1] Tavapadon[1] Tavapadon 💬 [2] DRD1,
DRD5 💬 		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6 💬
97 mg QD to 15 mg QD PF-06649751[1] Tavapadon[1] Tavapadon 💬 [2] DRD1,
DRD5 💬 		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6 💬
107 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)[1] Tavapadon[1] Tavapadon 💬 [2] DRD1,
DRD5 💬 		[10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6 💬
11Abatacept, rituximab or tocilizumab[3] Abatacept,
Rituximab,
Tocilizumab (Tocilizumab)		[3] Tocilizumab (Tocilizumab, Tocilizumab),
Rituximab ,
Abatacept 💬 		[4] CD80,
CD86,
IL6R,
MS4A1 💬 		[25] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬[1] 46 💬
12ABP 710 - Biosimilar to infliximab[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
13ABP 798 - Biosimilar to rituximab[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
14ABP 798 Biosimilar to Rituximab[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
15ABP 959 - biosimilar to eculizumab[1] Eculizumab[1] Eculizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
16ABP 959 - proposed biosimilar to eculizumab[1] Eculizumab[1] Eculizumab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[1] 62 💬
17AC-203 1% Topical Ointment----[1] 162 💬
18Active topical NS2 1% dermatologic cream----[1] 160 💬
19Adalimuab, Etanercept, Tocilizumab, or Abatacept[3] Abatacept,
Etanercept,
Tocilizumab (Tocilizumab)		[3] Etanercept ,
Tocilizumab (Tocilizumab, Tocilizumab),
Abatacept 💬 		[5] CD80,
CD86,
IL6R,
LTA,
TNF 💬 		[80] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
20Adalimumab (up to 9 months exposure)[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
21ADENO-ASSOCIATED VIRUS SEROTYPE 5 ENCODING A MICRORNA TARGETED TO HUMAN HUNTINGTIN GENE----[1] 8 💬
22ADX-102 1% Topical Dermal Cream (reproxalap)[1] Reproxalap[1] Reproxalap 💬 --[1] 160 💬
23Alpha-tocopherol[2] Tocopherol (tocoferol),
Vitamin E (Totalvit Plus)		[2] Vitamin E ,
Tocopherol (Tocopherol, dl-alpha-Tocopherol) 💬 		--[2] 49, 206 💬
24Alpha-tocotrienol quinone[1] Tocotrienol (Tocotrienol)---[2] 21, 156 💬
25Alpha-tocotrienolquinone----[1] 18 💬
26Also referred to as 'MEDI2070'----[2] 96, 97 💬
27Also referred to as MED2070----[1] 96 💬
28Also referred to as MEDI2070----[2] 96, 97 💬
29Alvelestat tosylate[1] Alvelestat---[1] 231 💬
30Amoxicillin, metronidazole and doxycycline
(METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL)		[3] Amoxicillin,
Doxycycline,
Metronidazole (Metronidazole Topical Cream)		[5] Amoxicillin ,
Doxycycline ,
Metronidazole (METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL),
Amoxicillin ,
Doxycycline 💬 		--[1] 97 💬
31AndroGel 1 % Topical Gel----[1] 13 💬
32Anesthetic Topical Adhesive Synera----[1] 13 💬
33Antiepileptic drug (1 to 3 only)----[1] 158 💬
34Apitox - pure honeybee toxin----[1] 13 💬
35Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E)[3] Ascorbic acid (Hot Lemon Ultra Strength Total Flu Night),
Tocopherol (tocoferol),
Vitamin E (Totalvit Plus)		[3] Ascorbic acid ,
Vitamin E ,
Tocopherol (Tocopherol, dl-alpha-Tocopherol) 💬 		--[1] 206 💬
36Atomoxetine
(Tomoxetine)		[1] Atomoxetine (Tomoxetinum)[1] Atomoxetine (Tomoxetine) 💬 [1] SLC6A2 💬 [1] Synaptic vesicle cycle 💬[4] 6, 8, 13, 17 💬
37Autologous mature tolerogenic monocyte-derived Dendritic Cells loaded with the B29 peptide of HSP70----[1] 46 💬
38Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3)[1] Myelin basic protein---[1] 13 💬
39Avonex and Topamax[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
40Azithromycin + Metronidazole
(METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL)		[2] Azithromycin,
Metronidazole (Metronidazole Topical Cream)		[3] Metronidazole (METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL),
Azithromycin ,
Azithromycin 💬 		--[1] 96 💬
41BDMARD withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept)[5] Abatacept,
Adalimumab,
Etanercept,
Golimumab,
Infliximab		[5] Etanercept ,
Adalimumab ,
Infliximab ,
Abatacept ,
Golimumab 💬 		[4] CD80,
CD86,
LTA,
TNF 💬 		[74] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
42Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour UDCA therapy[2] Bezafibrate,
Ursodeoxycholic acid (BAMBOO SALT Eunganggo Jook Yeom Toothpaste)		[2] Ursodiol ,
Bezafibrate 💬 		[2] NR1H4,
PPARA 💬 		[11] Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 94 💬
43BIIB067 (Tofersen)[1] Tofersen (Tofersen)[1] Tofersen (Tofersen) 💬 [1] SOD1 💬 [8] Amyotrophic lateral sclerosis, Chemical carcinogenesis - reactive oxygen species, Huntington disease, Longevity regulating pathway - multiple species, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Peroxisome, Prion disease 💬[1] 2 💬
44Biological: Benralizumab, Biological: Placebo to Mepolizumab[2] Benralizumab,
Mepolizumab		[2] Mepolizumab ,
Benralizumab 💬 		[2] IL5,
IL5RA 💬 		[13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[1] 44 💬
45Biological: Mepolizumab, Biological: Placebo to Benralizumab[2] Benralizumab,
Mepolizumab		[2] Mepolizumab ,
Benralizumab 💬 		[2] IL5,
IL5RA 💬 		[13] Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬[1] 44 💬
46Biosimilar product to adalimumab[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
47Bony Toxicity----[1] 34 💬
48Bortezomib D-mannitol
(Tobrex)		[3] Bortezomib,
Bortezomib D-mannitol,
Mannitol		[2] Mannitol (Tobrex),
Bortezomib 💬 		[1] PSMB5 💬 [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28 💬
49Botulinic toxin----[1] 36 💬
50Botulinum A toxin----[1] 118 💬
51Botulinum Toxin----[3] 6, 13, 149 💬
52Botulinum toxin A[1] Botulinum toxin type A (Botulinum toxin type A)[1] Botulinum toxin type A (Botulinum toxin type A) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[4] 13, 51, 149, 226 💬
53BOTULINUM TOXIN A - HAEMAGGLUTININ COMPLEX[1] Botulinum toxin type A (Botulinum toxin type A)[1] Botulinum toxin type A (Botulinum toxin type A) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
54BOTULINUM TOXIN TYPE A[1] Botulinum toxin type A (Botulinum toxin type A)[1] Botulinum toxin type A (Botulinum toxin type A) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[10] 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 💬
55Botulinum toxin type A (Nabota®) injection into the gastrocnemius muscle[1] Botulinum toxin type A (Botulinum toxin type A)[1] Botulinum toxin type A (Botulinum toxin type A) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 70 💬
56Botulinum Toxin Type A 200U[1] Botulinum toxin type A (Botulinum toxin type A)[1] Botulinum toxin type A (Botulinum toxin type A) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
57Botulinum Toxin Type A 300U[1] Botulinum toxin type A (Botulinum toxin type A)[1] Botulinum toxin type A (Botulinum toxin type A) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
58Botulinum toxin type B[1] Botulinum toxin type B (Botulinum toxin type B)[1] Rimabotulinumtoxin B (Botulinum toxin type B) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[3] 2, 6, 51 💬
59Botulinum toxin type B (2500 units / vial)[1] Botulinum toxin type B (Botulinum toxin type B)[1] Rimabotulinumtoxin B (Botulinum toxin type B) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 51 💬
60Botulinum toxin type B (Myobloc)[1] Botulinum toxin type B (Botulinum toxin type B)[1] Rimabotulinumtoxin B (Botulinum toxin type B) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[2] 2, 6 💬
61Botulinum toxin(Botox)[1] Botulinum toxin type A (Botulinum toxin type A)[1] Botulinum toxin type A (Botulinum toxin type A) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 51 💬
62Botulinum Toxin: Xeomin[1] Botulinum toxin type A (Botulinum toxin type A)[1] Botulinum toxin type A (Botulinum toxin type A) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 6 💬
63Botulism Toxin Treatment----[1] 161 💬
64C-82 Topical Gel, 1%----[1] 51 💬
65C-type natriuretic peptide conjugated to a multi-arm polyethylene glycol carrier molecule through a cleavable linker[1] Polyethylene glycol (Topcare ClearLax)[1] Polyethylene glycol 3350 💬 --[1] 276 💬
66C-TYPE NATRIURETIC PEPTIDE CONJUGATED TO MULTI-ARM POLYETHYLENE GLYCOL CARRIER THROUGH A CLEAVABLE LINKER[1] Polyethylene glycol (Topcare ClearLax)[1] Polyethylene glycol 3350 💬 --[1] 276 💬
67Ceftazidime and tobramycin[2] Ceftazidime,
Tobramycin (Tobi)		[3] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION),
Ceftazidime ,
Ceftazidime 💬 		--[1] 299 💬
68Chong Kun Dang Tofacitinib Tablet[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
69Cistanche Total Glycosides----[1] 2 💬
70Clobetasol 0.05% Topical Ointment[1] Clobetasol[1] Clobetasol 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 162 💬
71CLOSTRIDIUM BOTULINUM TOXIN TYPE A[2] Botulinum toxin type A (Botulinum toxin type A),
Clostridium botulinum		[1] Botulinum toxin type A (Botulinum toxin type A) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
72Cohort 1: hATG, CsA, EPAG Day 14 to Month 6[1] Antilymphocyte immunoglobulin (horse)---[1] 60 💬
73Cohort 2: hATG, CsA, EPAG Day 14 to Month 3[1] Antilymphocyte immunoglobulin (horse)---[1] 60 💬
74Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1)[1] Nilotinib[1] Nilotinib 💬 [4] ABL1,
KIT,
PDGFRA,
PDGFRB 💬 		[33] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬[1] 6 💬
75Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6[1] Antilymphocyte immunoglobulin (horse)---[1] 60 💬
76Combination Product: Beclomethasone dipropionate in addition to MC-EVOO[1] Beclomethasone dipropionate[1] Beclomethasone dipropionate 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
77Combination Product: Beclomethasone dipropionate in addition to refined oil[1] Beclomethasone dipropionate[1] Beclomethasone dipropionate 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
78Corticoids+ tocilizumab 8mg/Kg/4 weeks[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 41 💬
79Cotoretigene Toliparvovec[1] Cotoretigene toliparvovec (Cotoretigene toliparvovec)---[1] 90 💬
80CP-690,550 (tofacitinib)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 46, 107 💬
81CT-P47 AI (tocilizumab)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
82CT-P47 PFS (tocilizumab)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
83Cystic Fibrosis Ready to Use Supplemental Food----[1] 299 💬
84D-a-tocopheryl PEG 1000 succinate----[1] 299 💬
85Decrease Tocilizumab, Abatacept[2] Abatacept,
Tocilizumab (Tocilizumab)		[2] Tocilizumab (Tocilizumab, Tocilizumab),
Abatacept 💬 		[3] CD80,
CD86,
IL6R 💬 		[25] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬[1] 46 💬
86Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand[1] Denosumab[1] Denosumab 💬 [1] TNFSF11 💬 [8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 274 💬
87Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand[1] Denosumab[1] Denosumab 💬 [1] TNFSF11 💬 [8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[1] 274 💬
88Diclofenac sodium topical gel[1] Diclofenac (Diclofenac Topical Solution)[1] Diclofenac 💬 [2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 13 💬
89Diphtheria toxoid[1] Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (Diphtheria Toxoid)---[2] 13, 46 💬
90DP Mannitol
(Tobrex)		[1] Mannitol[1] Mannitol (Tobrex) 💬 --[1] 299 💬
91Dry powder tobramycin[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
92EGCG + Tocotrienol[2] Epigallocatechin gallate,
Tocotrienol (Tocotrienol)		---[1] 299 💬
93Essential amino acid intake + Leucine vs total AA supplement[1] Leucine[1] Leucine 💬 --[1] 299 💬
94Etanercepet, Rituximab, Abatacept, Tocilizumab, Sarilumab[4] Abatacept,
Rituximab,
Sarilumab,
Tocilizumab (Tocilizumab)		[4] Tocilizumab (Tocilizumab, Tocilizumab),
Rituximab ,
Abatacept ,
Sarilumab 💬 		[4] CD80,
CD86,
IL6R,
MS4A1 💬 		[25] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬[1] 46 💬
95Exposure to golimumab[1] Golimumab[1] Golimumab 💬 [1] TNF 💬 [67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
96Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS----[1] 13 💬
97Fluocinolone Acetonide
(FLUOCINOLONE ACETONIDE TOPICAL, FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01%)		[2] Fluocinolone,
Fluocinolone acetonide (Fluocinolone Acetonide Topical)		[1] Fluocinolone acetonide (FLUOCINOLONE ACETONIDE TOPICAL, FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01%) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 90 💬
98Furosemide
(14-PANEL TOXICOLOGY MEDICATED COLLECTION SYSTEM, TOXICOLOGY MEDICATED COLLECTION SYSTEM, TOXYCOLOGY MEDICATED COLLECTION SYSTEM)		[1] Furosemide (Toxicology Medicated Collection System)[1] Furosemide (14-PANEL TOXICOLOGY MEDICATED COLLECTION SYSTEM, TOXICOLOGY MEDICATED COLLECTION SYSTEM, TOXYCOLOGY MEDICATED COLLECTION SYSTEM) 💬 [1] SLC12A2 💬 [3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬[2] 6, 86 💬
99Furosemide Injection
(14-PANEL TOXICOLOGY MEDICATED COLLECTION SYSTEM, TOXICOLOGY MEDICATED COLLECTION SYSTEM, TOXYCOLOGY MEDICATED COLLECTION SYSTEM)		[1] Furosemide (Toxicology Medicated Collection System)[1] Furosemide (14-PANEL TOXICOLOGY MEDICATED COLLECTION SYSTEM, TOXICOLOGY MEDICATED COLLECTION SYSTEM, TOXYCOLOGY MEDICATED COLLECTION SYSTEM) 💬 [1] SLC12A2 💬 [3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬[1] 6 💬
100Gamma-Tocopherol[2] Tocopherol (tocoferol),
gamma-Tocopherol (gamma-Tocopherol)		[1] Tocopherol (Tocopherol, dl-alpha-Tocopherol) 💬 --[1] 13 💬
101GM-CSF, fosfomycin and metronidazole
(METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL)		[2] Fosfomycin,
Metronidazole (Metronidazole Topical Cream)		[2] Metronidazole (METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL),
Fosfomycin 💬 		--[1] 97 💬
102HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)[1] Clostridium tetani toxoid antigen (formaldehyde inactivated) (Tetanus toxoid)---[2] 13, 14 💬
103HOV-12020 (Palm tocotrienols complex)----[1] 124 💬
104Human Monoclonal Antibody (CNTO 1275) to Interleukin 12p-40----[1] 96 💬
105Human monoclonal antibody (CNTO 1275) to interleukin-12p40----[1] 13 💬
106HUMAN SERUM ALBUMIN (HSA) FUSED TO RECOMBINANT HUMAN GROWTH HORMONE (HGH)[2] Albumin human,
Somatotropin		[1] Albumin human 💬 --[1] 78 💬
107Human Serum Albumin (HSA) fused to somatropin[2] Albumin human,
Somatotropin		[1] Albumin human 💬 --[1] 78 💬
108IDPM: Inhaled Dry Powder Mannitol
(Tobrex)		[1] Mannitol[1] Mannitol (Tobrex) 💬 --[1] 299 💬
109IDURONATE-2-SULFATASE FUSED TO A FC POLYPEPTIDE THAT BINDS TO THE HUMAN TRANSFERRIN RECEPTOR----[1] 19 💬
110Iloprost therapy up to 2 ng/kg x min[1] Iloprost[1] Iloprost 💬 [1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 51 💬
111In double-blind phase: treatment with tofacitinib[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 107 💬
112In open-label phase: treatment with tofacitinib[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 107 💬
113Incobotulinum Toxin A----[3] 2, 6, 13 💬
114Inhaled Dry Powder Mannitol
(Tobrex)		[1] Mannitol[1] Mannitol (Tobrex) 💬 --[1] 299 💬
115Inhaled Mannitol
(Tobrex)		[1] Mannitol[1] Mannitol (Tobrex) 💬 --[1] 299 💬
116Inhaled tobramycin[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
117INN-Tocilizumab[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 266 💬
118Insulin glargine
(TOUJEO, TOUJEO MAX)		[1] Insulin glargine (Toujeo Solostar)[1] Insulin glargine (TOUJEO, TOUJEO MAX) 💬 [1] INSR 💬 [22] AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 299 💬
119Interferon beta treatment to add-on atorvastatin treatment[2] Atorvastatin,
Human interferon beta		[1] Atorvastatin 💬 [1] HMGCR 💬 [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 13 💬
120Intra-articular Tocilizumab[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
121Intradetrusor injection of Botulinum Toxin-A----[1] 13 💬
122Intravenous (i.v.) methylprednisolone 1000 mg, total 9[1] Methylprednisolone[1] Methylprednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 222 💬
123Intravesical injection of Botulinum A toxin----[2] 6, 17 💬
124IPD® (suplatast tosilate)----[1] 226 💬
125Itraconazole
(TOLSURA)		[1] Itraconazole (Tolsura)[1] Itraconazole (TOLSURA) 💬 --[6] 3, 46, 65, 96, 227, 299 💬
126Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally.
(TOLSURA)		[2] Itraconazole (Tolsura),
Terbinafine (Terbinafine HCl Chlortimazole and Tolnaftate)		[2] Itraconazole (TOLSURA),
Terbinafine 💬 		--[1] 96 💬
127Itraconazole/voriconazole
(TOLSURA)		[2] Itraconazole (Tolsura),
Voriconazole		[2] Itraconazole (TOLSURA),
Voriconazole 💬 		--[1] 299 💬
128Itraconazole? SHR0302 tablets
(TOLSURA)		[1] Itraconazole (Tolsura)[1] Itraconazole (TOLSURA) 💬 --[1] 46 💬
129IV tobramycin[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
130Jinarc - Tolvaptan tablets[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
131Ketorolac
(Toradol)		[1] Ketorolac (Toradol Inj 10mg/ml)[1] Ketorolac (Toradol) 💬 [2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[2] 70, 226 💬
132Ketorolac Tromethamine
(Toradol)		[2] Ketorolac (Toradol Inj 10mg/ml),
Tromethamine		[2] Tromethamine ,
Ketorolac (Toradol) 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 226 💬
133Lentivirus-mediated delivery of ARSA to the CNS.----[1] 19 💬
134Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field----[1] 13 💬
135LMX 4 Topical Cream----[1] 256 💬
136MabionCD20 (candidate biosimilar to rituximab)[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
137Mannitol
(Tobrex)		[1] Mannitol[1] Mannitol (Tobrex) 💬 --[7] 6, 13, 28, 60, 96, 113, 299 💬
138Mannitol + pulmozyme
(Tobrex)		[2] Dornase alfa,
Mannitol		[2] Mannitol (Tobrex),
Dornase alfa 💬 		--[1] 299 💬
139Mannitol Inhalant Product
(Tobrex)		[1] Mannitol[1] Mannitol (Tobrex) 💬 --[1] 299 💬
140Mannitol inhalation powder
(Tobrex)		[1] Mannitol[1] Mannitol (Tobrex) 💬 --[1] 299 💬
141Medication to suppress the immune system----[1] 19 💬
142MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN[2] Corynebacterium diphtheriae (Tetanus and Diphtheria Toxoids Adsorbed),
Corynebacterium diphtheriae CRM197 protein (Diphtheria toxin mutant CRM197)		---[1] 11 💬
143MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN[2] Corynebacterium diphtheriae (Tetanus and Diphtheria Toxoids Adsorbed),
Corynebacterium diphtheriae CRM197 protein (Diphtheria toxin mutant CRM197)		---[1] 11 💬
144MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN[2] Corynebacterium diphtheriae (Tetanus and Diphtheria Toxoids Adsorbed),
Corynebacterium diphtheriae CRM197 protein (Diphtheria toxin mutant CRM197)		---[1] 11 💬
145MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN[2] Corynebacterium diphtheriae (Tetanus and Diphtheria Toxoids Adsorbed),
Corynebacterium diphtheriae CRM197 protein (Diphtheria toxin mutant CRM197)		---[1] 11 💬
146MENINGOCOCCAL GROUP Y OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (Â197) M8 (CRM197) PROTEIN[2] Corynebacterium diphtheriae (Tetanus and Diphtheria Toxoids Adsorbed),
Corynebacterium diphtheriae CRM197 protein (Diphtheria toxin mutant CRM197)		---[1] 11 💬
147Metformin 500 Mg Oral Tablet, up to 4 tablets a day[1] Metformin[1] Metformin 💬 [2] PRKAA1,
PRKAA2 💬 		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[1] 13 💬
148Metronidazole
(METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL)		[1] Metronidazole (Metronidazole Topical Cream)[1] Metronidazole (METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL) 💬 --[7] 46, 51, 63, 94, 96, 97, 291 💬
149Metronidazole capsule 50 mg
(METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL)		[1] Metronidazole (Metronidazole Topical Cream)[1] Metronidazole (METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL) 💬 --[1] 97 💬
150Metronidazole Oral
(METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL)		[1] Metronidazole (Metronidazole Topical Cream)[1] Metronidazole (METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL) 💬 --[1] 96 💬
151Midodrine or atomoxetine pill
(Tomoxetine)		[2] Atomoxetine (Tomoxetinum),
Midodrine		[2] Atomoxetine (Tomoxetine),
Midodrine 💬 		[4] ADRA1A,
ADRA1B,
ADRA1D,
SLC6A2 💬 		[8] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Synaptic vesicle cycle, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 17 💬
152Minibody against CD8 conjugated to desferrioxamine labeled with zirconium Zr 89[1] Deferoxamine[1] Deferoxamine 💬 --[2] 51, 53 💬
153Mobilization of stem cells to prepare for Leukapheresis----[1] 96 💬
154Modified Oral Glucose Tolerance Test (50g 4-hours)[1] Dextrose, unspecified form (100gm Glucose Tolerance Drink)---[1] 299 💬
155Most recent vaccine to seasonal influenza----[1] 13 💬
156MRA (Tocilizumab)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 107 💬
157MRA(Tocilizumab)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 107 💬
158MSC2430913A or ONO-4641 (to be used as synonyms)----[1] 13 💬
159MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF----[1] 2 💬
160Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides)[1] Myelin basic protein---[1] 13 💬
161N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO----[1] 11 💬
162N. MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 ADSORBED ON ALUMINUM HYDROXIDE[5] Aluminium,
Aluminum hydroxide (Topcare Antacid Plus Anti Gas),
Corynebacterium diphtheriae (Tetanus and Diphtheria Toxoids Adsorbed),
Corynebacterium diphtheriae CRM197 protein (Diphtheria toxin mutant CRM197),
Hydroxide ion		[1] Aluminum hydroxide 💬 --[1] 11 💬
163Nanobody directed towards the human A1 domain of von Willebrand factor[1] Von Willebrand factor human---[1] 64 💬
164Nebcin (tobramycin)[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
165Nebcinal Tobi----[1] 299 💬
166Nebulization tobramycin[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
167NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED WITH TETANUS TOXOID CARRIER PROTEIN[1] Clostridium tetani toxoid antigen (formaldehyde inactivated) (Tetanus toxoid)---[1] 50 💬
168NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETA[1] Triethylenetetramine---[1] 50 💬
169NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN[1] Clostridium tetani toxoid antigen (formaldehyde inactivated) (Tetanus toxoid)---[1] 50 💬
170Onabotulinum Toxin A----[1] 226 💬
171OPC-41061 (tolvaptan)[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
172Open Label Topical Beremagene Geperpavec (B-VEC)----[1] 36 💬
173Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone[2] Mesalazine,
Methylprednisolone		[2] Mesalamine ,
Methylprednisolone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
174Oral Glucose Tolerance test (75g 2-hour)[1] Dextrose, unspecified form (100gm Glucose Tolerance Drink)---[1] 299 💬
175OSU 6162 similar to (-)-OSU 6162----[1] 6 💬
176OSU6162 similar to (-)-OSU 6162----[2] 6, 8 💬
177Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254measured as amount of total protein containing the PorA P1.4----[1] 11 💬
178Oxybutynin, tolterodine, solifenacin[3] Oxybutynin,
Solifenacin,
Tolterodine (Ran-tolterodine)		[3] Oxybutynin ,
Tolterodine (Tolterodine),
Solifenacin 💬 		[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		[13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 53 💬
179Patients will be randomized to receive EHP-101----[1] 51 💬
180Pertussis toxoid[1] Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated))---[1] 46 💬
181PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE[4] Aluminium,
Aluminum hydroxide (Topcare Antacid Plus Anti Gas),
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)),
Hydroxide ion		[1] Aluminum hydroxide 💬 --[1] 46 💬
182Pharmacologic approaches to glycemic treatment----[1] 298 💬
183Phentermine-Topiramate[2] Phentermine,
Topiramate (Topiramate Tablets USP)		[2] Topiramate (Topiramate, Topamax),
Phentermine 💬 		[41] CA2,
CA4,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
MAOA,
MAOB,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SLC6A2,
SLC6A3,
SLC6A4 💬 		[63] Adrenergic signaling in cardiomyocytes, Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arginine and proline metabolism, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, Drug metabolism - cytochrome P450, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycine, serine and threonine metabolism, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Histidine metabolism, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Phenylalanine metabolism, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Synaptic vesicle cycle, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Tryptophan metabolism, Type II diabetes mellitus, Tyrosine metabolism, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 97 💬
184PLA + MTX switched to ABA+ MTX, DB----[1] 46 💬
185PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED) CONJUGATED TO CRM197 CARRIER PROTEIN AND ADSORBED ON ALUMINIUM PHOSPHATE[4] Aluminium,
Aluminium phosphate,
Corynebacterium diphtheriae CRM197 protein (Diphtheria toxin mutant CRM197),
Phosphate ion		---[1] 46 💬
186Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin)[1] Activated charcoal---[1] 6 💬
187Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin)----[1] 6 💬
188Previously referred to as MEDI2070 and AMG 139----[2] 96, 97 💬
189Previously referred to as MEDI2070 and AMG 139, AGN-151-598----[1] 96 💬
190PXT3003 Dose 2 (equivalent to twice Dose 1)----[1] 10 💬
191QR-313 Gel for Topical (Cutaneous) Administration----[1] 36 💬
192Rapamycin cream, topical, 0.5%, 1.0% w/w[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 158 💬
193RECOMBINANT HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 FUSED TO THE FC FRAGMENT OF IGG1----[1] 166 💬
194Recombinant human monoclonal antibody to human IL-1Beta of the IgG1/K class----[3] 106, 107, 108 💬
195Recombinant human monoclonal antibody to Il-17 of the IgG1-k-class----[1] 271 💬
196Recombinant human monoclonal antibody to inerleukin-1beta of the IgG1-K-class----[1] 46 💬
197Recombinant human monoclonal antibody to interleukin-1beta of the IgG1-Kappa-class----[1] 46 💬
198RECOMBINANT HUMAN SERUM ALBUMIN (HSA) FUSED TO HUMAN GROWTH HORMONE (HGH)[2] Albumin human,
Somatotropin		[1] Albumin human 💬 --[1] 78 💬
199Recombinant humanized monoclonal antibody omalizumab to IgE[1] Omalizumab[1] Omalizumab 💬 [1] FCER1A 💬 [4] Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway 💬[1] 299 💬
200Reduced Toxicity Ablative Regimen----[3] 62, 65, 284 💬
201Response to anakinra associated with methotrexate[2] Anakinra,
Methotrexate		[2] Methotrexate ,
Anakinra 💬 		[4] DHFR,
DHFR2,
IL1R1,
IL1R2 💬 		[20] Amoebiasis, Antifolate resistance, Biosynthesis of cofactors, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Metabolic pathways, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[1] 46 💬
202Response to infliximab associated with methotrexate[2] Infliximab,
Methotrexate		[2] Methotrexate ,
Infliximab 💬 		[3] DHFR,
DHFR2,
TNF 💬 		[71] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
203RhumAb to Il-17A (IgG1-k-class)----[4] 13, 46, 56, 96 💬
204RhumAb to Il-17A (IgG1-k-class) rhumAb to Il-17A (IgG1-k-class)----[1] 96 💬
205RhumAb to IL-17A igG1-k-class----[1] 13 💬
206RoActemra/Actemra (tocilizumab)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 107 💬
207RPC1063 (equivalent to ozanimod[1] Ozanimod[1] Ozanimod 💬 [5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 96 💬
208RPC1063 (equivalent to ozanimod HCl)[1] Ozanimod[1] Ozanimod 💬 [5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 96 💬
209RPC1063 equiv to ozanimod HCI[1] Ozanimod[1] Ozanimod 💬 [5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 96 💬
210RPC1063 equiv. to ozanimod HCI[1] Ozanimod[1] Ozanimod 💬 [5] S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬 		[3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬[1] 96 💬
211SB2 (proposed biosimilar to infliximab)[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
212SB4 (proposed biosimilar to etanercept)[1] Etanercept[1] Etanercept 💬 [2] LTA,
TNF 💬 		[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
213SB5 (proposed biosimilar to adalimumab)[1] Adalimumab[1] Adalimumab 💬 [1] TNF 💬 [67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
214Sorafenib (as tosylate)[1] Sorafenib (Sorafenib Tosylate)[1] Sorafenib 💬 [8] BRAF,
FLT3,
FLT4,
KDR,
KIT,
PDGFRB,
RAF1,
RET 💬 		[89] Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 34 💬
215Subcutaneous tocilizumab[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
216Subcutaneous tocilizumab 162mg/biweekly[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
217Suplatast tosilate----[1] 226 💬
218Switch to Myfortic[1] Mycophenolic acid[1] Mycophenolic acid 💬 [2] IMPDH1,
IMPDH2 💬 		[4] Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬[1] 49 💬
219Takecab tablets + amoxicillin + clarithromycin (first-line eradication) Takecab tablets + amoxicillin + metronidazole (second-line eradication)
(METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL)		[3] Amoxicillin,
Clarithromycin,
Metronidazole (Metronidazole Topical Cream)		[4] Amoxicillin ,
Clarithromycin ,
Metronidazole (METRONIDAZOLE TOPICAL CREAM, METRONIDAZOLE TOPICAL GEL),
Amoxicillin 💬 		--[1] 63 💬
220Tedizolid
(Torezolid)		[1] Tedizolid (Torezolid)[1] Tedizolid (Torezolid) 💬 --[1] 299 💬
221Tedizolid IV
(Torezolid)		[1] Tedizolid (Torezolid)[1] Tedizolid (Torezolid) 💬 --[1] 299 💬
222Tedizolid PO
(Torezolid)		[1] Tedizolid (Torezolid)[1] Tedizolid (Torezolid) 💬 --[1] 299 💬
223Temsirolimus
(Torisel)		[1] Temsirolimus (Torisel)[1] Temsirolimus (Torisel) 💬 [1] MTOR 💬 [51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 13 💬
224Temsirolimus Tablets
(Torisel)		[1] Temsirolimus (Torisel)[1] Temsirolimus (Torisel) 💬 [1] MTOR 💬 [51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 13 💬
225Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleava[2] Polyethylene glycol (Topcare ClearLax),
Teriparatide		[2] Polyethylene glycol 3350 ,
Teriparatide 💬 		[1] PTH1R 💬 [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235 💬
226Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker[2] Polyethylene glycol (Topcare ClearLax),
Teriparatide		[2] Polyethylene glycol 3350 ,
Teriparatide 💬 		[1] PTH1R 💬 [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬[1] 235 💬
227Tetanus diphtheria toxoid vaccine (Td)[1] Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (Diphtheria Toxoid)---[1] 13 💬
228Tetanus diphtheria toxoids vaccine----[1] 13 💬
229Tetanus toxoid[1] Clostridium tetani toxoid antigen (formaldehyde inactivated) (Tetanus toxoid)---[4] 13, 14, 46, 50 💬
230Tetanus toxoid (TT) containing vaccine (Td, Tdap)[1] Clostridium tetani toxoid antigen (formaldehyde inactivated) (Tetanus toxoid)---[1] 13 💬
231Tetanus toxoid adsorbed[1] Clostridium tetani toxoid antigen (formaldehyde inactivated) (Tetanus toxoid)---[1] 46 💬
232Tetanus toxoid adsorbed booster vaccine[1] Clostridium tetani toxoid antigen (formaldehyde inactivated) (Tetanus toxoid)---[1] 46 💬
233Tetanus Toxoid Adsorbed Vaccine[1] Clostridium tetani toxoid antigen (formaldehyde inactivated) (Tetanus toxoid)---[1] 46 💬
234Tetanus toxoid vaccine[1] Clostridium tetani toxoid antigen (formaldehyde inactivated) (Tetanus toxoid)---[1] 13 💬
235Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed)[3] Clostridium tetani toxoid antigen (formaldehyde inactivated) (Tetanus toxoid),
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (Diphtheria Toxoid),
Pertussis vaccine (Diphtheria and Tetanus Toxoids With Pertussis Vaccine Adsorbed)		[1] Pertussis vaccine 💬 --[1] 46 💬
236The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA----[1] 96 💬
237The investigational medicinal product (IMP) will be labeled as PF-04236921 106 mg/vial, Clonal SC lyophilized form, which is equivalent to PF-04236921 Powder for Injection, 106 mg/vial as described in the enclosed CTA.----[1] 96 💬
238Time delay treatment of botulinum toxin----[1] 149 💬
239TIP (Tobramycin inhalation powder)[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
240TIS (Tobramycin Inhalation Solution)[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
241TO----[1] 6 💬
242To be confirmed----[3] 46, 65, 97 💬
243To be determined----[2] 96, 113 💬
244To be requested----[2] 96, 97 💬
245TOBI[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
246TOBI (tobramycin)[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
247TOBI 300 mg / 5 mL nebuliser solution[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
248TOBI 300 mg/5 ml Lösung für einen[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
249TOBI 300 mg/5 ml Lösung für einen Vernebler[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
250TOBI 300 mg/5 ml Nebuliser Solution[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
251TOBI 300 mg/5 ml solución para inhalación por nebulizador[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
252TOBI 300 mg/5 ml, solution pour inhalation par nébuliseur[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
253TOBI 300mg/ 5ml solución para inhalación con nebulizador[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
254TOBI 300mg/5mL Nebuliser Solution[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
255Tobi 300mg/5ml Nebuliser solution.[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
256Tobi 300mg/5ml Solución para inhalación por nebulizador.[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
257Tobi Inhalant Product[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
258Tobi Nebcinal----[1] 299 💬
259TOBI PODHALER[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
260TOBI PODHALER - 28 MG POLVERE PER INALAZIONE CAPSULA RIGIDA USO INALATORIO BLISTER(ALU/ALU) 56 CAPSULE + 1 INALATORE[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
261TOBI Podhaler 28 mg Hartkapseln mit Pulver zur Inhalation[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
262TOBI Podhaler 28 mg inhalációs por, kemény kapszula[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
263TOBI PODHALER*448CPS 28MG+10IN[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
264TOBI*NEBUL 56F 1D 300MG/5ML[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
265TOBI®[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
266TOBI™ Podhaler™ 112 mg inhaled twice daily----[1] 299 💬
267Tobramcyin----[1] 299 💬
268TOBRAMICINA[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
269Tobramicina polvere inalatoria[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
270TOBRAMICINA SOLFATO[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
271Tobramicyn----[1] 299 💬
272TOBRAMYCIN[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
273Tobramycin (Gernebcin®)[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
274Tobramycin / Bramitob[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
275Tobramycin / TOBI[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
276Tobramycin 100 PARI[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
277Tobramycin dry powder[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
278Tobramycin for Inhalation[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
279Tobramycin Inhalation Powder[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
280Tobramycin Inhalation Powder (TIP)[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
281Tobramycin Inhalation Powder TIP delivered by the T-326 Inhaler[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
282Tobramycin inhalation solution[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
283Tobramycin Inhalation Solution (TIS)[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
284Tobramycin inhalation solution using a PARI LC® Plus nebulizer.[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
285Tobramycin injection 40mg/1ml[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
286Tobramycin nebulized nasally[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
287Tobramycin Powder[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
288Tobramycin Solution for Inhalation[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
289Tobramycin solution for inhalation (TOBI)[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
290Tobramycin solution for inhalation 300 mg[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
291Tobramycin Steri-Neb 300 mg/5 ml, inhalation solution[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
292TOBRAMYCIN SULFATE[2] Sulfate ion,
Tobramycin (Tobi)		[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
293Tobramycine[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
294Tobramycinum[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
295Tobrineb/Bramitob----[1] 299 💬
296Tocilizmab----[1] 46 💬
297Tocilizumab[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[21] 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
298Tocilizumab (Actemra or RoActemra)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
299Tocilizumab (Actemra)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
300Tocilizumab (Actemra®)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
301Tocilizumab (MRA-SC)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 40 💬
302Tocilizumab (TCZ)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 56 💬
303Tocilizumab + Glucocorticoids (GCs)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 41 💬
304Tocilizumab + methotrexate(MTX)[2] Methotrexate,
Tocilizumab (Tocilizumab)		[2] Methotrexate ,
Tocilizumab (Tocilizumab, Tocilizumab) 💬 		[3] DHFR,
DHFR2,
IL6R 💬 		[17] Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
305Tocilizumab 162 mg[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
306Tocilizumab 162Mg/0.9Ml Autoinjector[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 41 💬
307Tocilizumab 162mg/0.9ml jeringa SC[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
308Tocilizumab 162mg/0.9ml SC PFS SC[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
309Tocilizumab 162mg/0.9ml syringe SC[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
310Tocilizumab [RoActemra/Actemra][1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[4] 46, 51, 107, 331 💬
311Tocilizumab [RoActemra][1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
312Tocilizumab and IV steroids combination[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 41 💬
313Tocilizumab Infusion RoAcemtra (EU)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 266 💬
314Tocilizumab Injectable Product[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 11 💬
315Tocilizumab Injection[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13 💬
316Tocilizumab Injection 8mg/kg[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
317Tocilizumab IV[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
318Tocilizumab plus methotrexate[2] Methotrexate,
Tocilizumab (Tocilizumab)		[2] Methotrexate ,
Tocilizumab (Tocilizumab, Tocilizumab) 💬 		[3] DHFR,
DHFR2,
IL6R 💬 		[17] Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
319Tocilizumab Prefilled Syringe[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 41, 46 💬
320Tocilizumab Roche[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[2] 46, 107 💬
321TOCILIZUMAB SC[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[3] 41, 46, 107 💬
322Tocilizumab SC 162 mg/0.9 ml disposable auto-injector (AI)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
323Tocilizumab SC 162 mg/0.9 ml pre-filled syringe with safety device (PFS)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
324Tocilizumab SC 162 mg/0.9 ml prefilled syringe with safety device (PFS)[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 51 💬
325Tocilizumab treatment[1] Tocilizumab (Tocilizumab)[1] Tocilizumab (Tocilizumab, Tocilizumab) 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 41 💬
326Tocilizumab+Methotrexate(MTX)[2] Methotrexate,
Tocilizumab (Tocilizumab)		[2] Methotrexate ,
Tocilizumab (Tocilizumab, Tocilizumab) 💬 		[3] DHFR,
DHFR2,
IL6R 💬 		[17] Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 46 💬
327Tocilizumab, Abatacept[2] Abatacept,
Tocilizumab (Tocilizumab)		[2] Tocilizumab (Tocilizumab, Tocilizumab),
Abatacept 💬 		[3] CD80,
CD86,
IL6R 💬 		[25] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬[1] 46 💬
328Tocilizumabum----[1] 46 💬
329Tociluzumab----[1] 65 💬
330Tocoferol[1] Tocopherol (tocoferol)[1] Tocopherol (Tocopherol, dl-alpha-Tocopherol) 💬 --[1] 90 💬
331Tocopherol[1] Tocopherol (tocoferol)[1] Tocopherol (Tocopherol, dl-alpha-Tocopherol) 💬 --[5] 13, 49, 206, 257, 298 💬
332Tocopherol (vit E)[1] Tocopherol (tocoferol)[1] Tocopherol (Tocopherol, dl-alpha-Tocopherol) 💬 --[1] 257 💬
333Tocopherol acetate[3] Acetate,
Tocopherol (tocoferol),
alpha-Tocopherol acetate (TOOTH NOTE Moisturizing Therapy Tooth LEMON BASIL)		[1] Tocopherol (Tocopherol, dl-alpha-Tocopherol) 💬 --[1] 49 💬
334TOCOPHERYL ACETATE[2] Acetate,
alpha-Tocopherol acetate (TOOTH NOTE Moisturizing Therapy Tooth LEMON BASIL)		---[1] 206 💬
335Tocotrienol[1] Tocotrienol (Tocotrienol)---[3] 21, 156, 299 💬
336Tocotrienols----[1] 2 💬
337Tocovid Suprabio (HOV-12020)----[1] 6 💬
338Toctino[1] Alitretinoin (Toctino)[1] Alitretinoin 💬 [5] RARA,
RARB,
RXRA,
RXRB,
RXRG 💬 		[19] Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬[1] 49 💬
339Toctino®[1] Alitretinoin (Toctino)[1] Alitretinoin 💬 [5] RARA,
RARB,
RXRA,
RXRB,
RXRG 💬 		[19] Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬[1] 49 💬
340TOFACINITIB----[1] 97 💬
341Tofacitinb----[1] 46 💬
342Tofacitinib[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
343Tofacitinib (CP-690,550)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 96 💬
344Tofacitinib (Xeljanz)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
345Tofacitinib (Xeljanz®)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
346Tofacitinib (Xeljanz®) 11mg Prolonged Release Tablet[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
347Tofacitinib 10 mg[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 271 💬
348Tofacitinib 10 MG [Xeljanz][1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
349Tofacitinib 2 mg[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 271 💬
350Tofacitinib 5 MG[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[4] 11, 40, 46, 271 💬
351Tofacitinib 5 MG [Xeljanz][1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 46, 50 💬
352Tofacitinib 5 mg twice daily[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 84 💬
353Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 84 💬
354Tofacitinib 5mg po bid[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
355Tofacitinib citate (Phase III formulation)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
356TOFACITINIB CITRATE[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[5] 46, 49, 97, 107, 271 💬
357Tofacitinib citrate (clinical trial image)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 46, 97 💬
358Tofacitinib citrate (commercial image)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
359Tofacitinib citrate (Phase III formulation)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 46, 97 💬
360Tofacitinib citrate (Proposed commercial formulation - debossed)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 46, 97 💬
361Tofacitinib citrate (Proposed commercial formulation debossed)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
362Tofacitinib citrate (Proposed commercial formulation – debossed)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 46, 97 💬
363Tofacitinib citrate (Proposed commercial formulation- debossed)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
364Tofacitinib citrate (Proposed commercialFormulation - debossed)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 97 💬
365TOFACITINIB CITRATE CP-690550[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
366Tofacitinib citrate( Phase III formulation)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
367Tofacitinib or Baricitinib[2] Baricitinib,
Tofacitinib (Jamp Tofacitinib)		[2] Tofacitinib (Tofacitinib),
Baricitinib 💬 		[4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
368Tofacitinib tablet[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 40 💬
369Tofacitinib with methotrexate[2] Methotrexate,
Tofacitinib (Jamp Tofacitinib)		[2] Methotrexate ,
Tofacitinib (Tofacitinib) 💬 		[6] DHFR,
DHFR2,
JAK1,
JAK2,
JAK3,
TYK2 💬 		[42] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
370Tofacitinib without methotrexate[2] Methotrexate,
Tofacitinib (Jamp Tofacitinib)		[2] Methotrexate ,
Tofacitinib (Tofacitinib) 💬 		[6] DHFR,
DHFR2,
JAK1,
JAK2,
JAK3,
TYK2 💬 		[42] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
371Tofacitinib XR[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 46, 271 💬
372Tofacitinib/baricitinib[2] Baricitinib,
Tofacitinib (Jamp Tofacitinib)		[2] Tofacitinib (Tofacitinib),
Baricitinib 💬 		[4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
373Tofacitinibe citrate----[1] 107 💬
374Tofersen[1] Tofersen (Tofersen)[1] Tofersen (Tofersen) 💬 [1] SOD1 💬 [8] Amyotrophic lateral sclerosis, Chemical carcinogenesis - reactive oxygen species, Huntington disease, Longevity regulating pathway - multiple species, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Peroxisome, Prion disease 💬[1] 2 💬
375TOL----[1] 67 💬
376Tolcapon[1] Tolcapone (Tolcaponum)[1] Tolcapone (Tolcapone) 💬 [1] COMT 💬 [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬[1] 6 💬
377TOLCAPONE[1] Tolcapone (Tolcaponum)[1] Tolcapone (Tolcapone) 💬 [1] COMT 💬 [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬[3] 6, 28, 127 💬
378TolDC----[1] 46 💬
379Tolebrutinib----[2] 11, 13 💬
380Tolebrutinib 120mg----[1] 13 💬
381Tolebrutinib 60mg----[1] 13 💬
382Tolebrutininb----[1] 11 💬
383Tolerogenic dendritic cells----[2] 46, 96 💬
384Tolerogenic dendritic cells (tolDC)----[1] 13 💬
385Tolerogenic Dendritic cells loaded with myelin peptides[1] Myelin basic protein---[1] 13 💬
386Tolerogenic Fibroblasts----[1] 13 💬
387Tolfenamic Acid[1] Tolfenamic acid (Acide tolfenamique)[1] Tolfenamic acid (Tolfenamic acid) 💬 [2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 5 💬
388Tolicizumab----[1] 46 💬
389Tolicizumab Roche----[1] 46 💬
390Tolperisone[1] Tolperisone (Tolperisone)[1] Tolperisone (Tolperisone) 💬 --[1] 13 💬
391Tolperisone HC1[1] Tolperisone (Tolperisone)[1] Tolperisone (Tolperisone) 💬 --[1] 13 💬
392Tolperisone HCl[1] Tolperisone (Tolperisone)[1] Tolperisone (Tolperisone) 💬 --[1] 13 💬
393Tolpersan----[1] 13 💬
394Tolposan----[1] 13 💬
395Tolterodine[1] Tolterodine (Ran-tolterodine)[1] Tolterodine (Tolterodine) 💬 [1] CHRM3 💬 [11] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬[2] 17, 53 💬
396Tolubuterol Hydrochloride----[1] 6 💬
397TOLVAPTAN[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[4] 67, 72, 86, 225 💬
398TOLVAPTAN (OPC-41061)[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
399Tolvaptan (SAMSCA)[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 72 💬
400TOLVAPTAN 15[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
401Tolvaptan 15 mg Tablet[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
402Tolvaptan 15 mg tablets[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
403Tolvaptan 15mg[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
404TOLVAPTAN 30[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
405Tolvaptan 30 mg Tablet[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
406Tolvaptan 30 mg tablets[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
407Tolvaptan 30mg[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
408TOLVAPTAN 45/15[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
409Tolvaptan 50mg Granules[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
410TOLVAPTAN 60/30[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
411Tolvaptan 7.5 mg Tablet[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
412Tolvaptan in euvolemic hyponatremia[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 72 💬
413Tolvaptan IR[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
414Tolvaptan MR[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
415Tolvaptan Oral Tablet[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 72 💬
416Tolvaptan Suspension[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
417Tolvaptan Tablets[1] Tolvaptan (Tolvaptan)[1] Tolvaptan (Tolvaptan) 💬 [1] AVPR2 💬 [3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
418Tominersen----[1] 8 💬
419Tominersen 100 mg----[1] 8 💬
420Tominersen 60 mg----[1] 8 💬
421Top down treatment if patient at high risk----[2] 96, 97 💬
422Top-down----[1] 96 💬
423TOP1288----[1] 97 💬
424TOP1288 Rectal solution----[1] 97 💬
425TOPAMAX[1] Topiramate (Topiramate Tablets USP)[1] Topiramate (Topiramate, Topamax) 💬 [36] CA2,
CA4,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[53] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 140 💬
426Topical 0.1% Sirolimus[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 278 💬
427Topical AmphiMatrix----[1] 51 💬
428Topical AmphiMatrix with nitroglycerin (MQX-503)[1] Nitroglycerin[1] Nitroglycerin 💬 --[1] 51 💬
429Topical beremagene geperpavec----[1] 36 💬
430Topical BPM31510 3.0% Cream----[1] 36 💬
431Topical calcipotriene 0.005% ointment[1] Calcipotriol (Dovonex Solution - Top 50mcg/ml)[1] Calcipotriene 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 51 💬
432Topical compound tripterygium[1] Tripterygium wilfordii whole---[1] 46 💬
433Topical garamycin cream----[2] 35, 162 💬
434Topical infliximab[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[3] 38, 39, 162 💬
435Topical opiod----[1] 36 💬
436Topical organogel with nitroglycerin[1] Nitroglycerin[1] Nitroglycerin 💬 --[1] 51 💬
437Topical Pentoxifylline Gel (Vehicle +PTX)[1] Pentoxifylline[1] Pentoxifylline 💬 --[1] 56 💬
438Topical Preparation H arm----[1] 13 💬
439Topical Rapamycin[1] Sirolimus[1] Sirolimus 💬 [1] MTOR 💬 [51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 157 💬
440Topical timolol maleate[1] Timolol[2] Timolol ,
Timolol 💬 		[2] ADRB1,
ADRB2 💬 		[11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 227 💬
441Topical tripterygium gel[1] Tripterygium wilfordii whole---[1] 46 💬
442Topical Vehicle----[1] 278 💬
443Topimarate----[1] 144 💬
444Topimarato----[1] 144 💬
445TOPIRAMATE[1] Topiramate (Topiramate Tablets USP)[1] Topiramate (Topiramate, Topamax) 💬 [36] CA2,
CA4,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[53] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[6] 6, 97, 140, 144, 156, 193 💬
446Topiramate (drug)[1] Topiramate (Topiramate Tablets USP)[1] Topiramate (Topiramate, Topamax) 💬 [36] CA2,
CA4,
CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ,
GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		[53] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
447Topotecan[1] Topotecan (PMS-topotecan)[1] Topotecan (Topotecan) 💬 [1] TOP1 💬 -[1] 25 💬
448Torvast----[1] 13 💬
449TORVAST*10CPR 10MG----[1] 13 💬
450Total Body Irradiation----[1] 65 💬
451Total Body Irradiation (TBI) (Plan 1)----[2] 60, 285 💬
452Total Dietary Replacement----[1] 265 💬
453Total Glucosides Paeony Capsules----[1] 271 💬
454TOTTIZIM - 1 G/10 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO ENDOVENOSO 1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 10 ML----[1] 299 💬
455Tovaxin----[1] 13 💬
456Tovaxin Autologous T Cell Vaccine----[1] 13 💬
457Toxicity, Pharmacokinetics----[1] 34 💬
458TOZ----[1] 6 💬
459TOZADENANT[1] Tozadenant (Tozadenant)[1] Tozadenant (Tozadenant) 💬 [1] ADORA2A 💬 [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6 💬
460Tozadenant (SYN115) 120 mg BID[1] Tozadenant (Tozadenant)[1] Tozadenant (Tozadenant) 💬 [1] ADORA2A 💬 [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6 💬
461Tozadenant (SYN115) 180 mg BID[1] Tozadenant (Tozadenant)[1] Tozadenant (Tozadenant) 💬 [1] ADORA2A 💬 [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6 💬
462Tozadenant (SYN115) 240 mg BID[1] Tozadenant (Tozadenant)[1] Tozadenant (Tozadenant) 💬 [1] ADORA2A 💬 [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6 💬
463Tozadenant (SYN115) 60 mg BID[1] Tozadenant (Tozadenant)[1] Tozadenant (Tozadenant) 💬 [1] ADORA2A 💬 [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬[1] 6 💬
464Tozinameran[1] Tozinameran (Tozinameran)[1] Tozinameran (Tozinameran, Tozinameran and riltozinameran, Tozinameran and famtozinameran) 💬 --[1] 299 💬
465Treat to target----[1] 46 💬
466Treatment with topical superpotent corticosteroid therapy----[1] 162 💬
467Untreated to atorvastatin treatment[1] Atorvastatin[1] Atorvastatin 💬 [1] HMGCR 💬 [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 13 💬
468Urine samples taken to measure methotrexate and its major metabolite 7-OH-methotrexate level[1] Methotrexate[1] Methotrexate 💬 [2] DHFR,
DHFR2 💬 		[5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬[1] 46 💬
469Ursodeoxycholic acid combined with total glucosides of paeony[1] Ursodeoxycholic acid (BAMBOO SALT Eunganggo Jook Yeom Toothpaste)[1] Ursodiol 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
470VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO----[2] 61, 62 💬
471Vantobra (tobramycin)[1] Tobramycin (Tobi)[1] Tobramycin (Tobramycin, Tobi, Tobracin, Tobrex, TOBI PODHALER, TOBRAMYCIN INHALATION, TOBRAMYCIN INHALATION SOLUTION, TOBRAMYCIN OPHTHALMIC SOLUTION) 💬 --[1] 299 💬
472Vedolizumab, Ustekinumab, or Tofacitinib[3] Tofacitinib (Jamp Tofacitinib),
Ustekinumab,
Vedolizumab		[3] Vedolizumab ,
Ustekinumab ,
Tofacitinib (Tofacitinib) 💬 		[9] IL12A,
IL12B,
IL23A,
ITGA4,
ITGB7,
JAK1,
JAK2,
JAK3,
TYK2 💬 		[65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Focal adhesion, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Yersinia infection 💬[1] 97 💬
473Vehicle of ADX-102 Topical Dermal Cream----[1] 160 💬
474Wound topically irrigated with 500mg TXA----[1] 70 💬
475XELJANZ (tofacitinib)[1] Tofacitinib (Jamp Tofacitinib)[1] Tofacitinib (Tofacitinib) 💬 [4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[37] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 65 💬
476ZX008 0.2 to 0.8 mg/kg/day----[2] 140, 144 💬